Boyapati A, et al. High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response. ACR 2018, abstract L08.
Neuropsychiatrische lupus bij early- en late-onset SLE: een systematische review en meta-analyse
nov 2023 | SLE